Plasmon-Enhanced Fluoro-Dot Assay for Single-Cell Protein Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting protein secretion by cells, such as ELISA and mass spectrometry, fail to resolve spatial and temporal patterns at a single-cell level, masking cell-to-cell heterogeneity and locoregional correlations, and are limited by low sensitivity and the need for extensive sample collection and specialized equipment.

Innovation Solution

The plasmon-enhanced fluoro-dot assay uses ultrabright plasmonic-fluors to detect and quantify protein secretion at a single-cell level, allowing for real-time imaging and digital quantification of protein secretion patterns, enabling the observation of biophysical and biochemical correlations without relying on mRNA levels or specialized instrumentation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional ELISA or mass spectrometry methods are used to detect protein secretion, then the detection can be performed with standard equipment, but the spatial and temporal resolution at single-cell level is lost and cell-to-cell heterogeneity is masked

Engineering Contradiction:
Improvespatial and temporal resolutionVSAvoidspecialized equipment requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention segments the detection process into single-cell level analysis by capturing individual cells on a substrate and detecting proteins secreted by each cell separately. This segmentation enables spatial resolution at the single-cell level while using conventional ELISA equipment, thus resolving the contradiction between measurement precision and device complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces an intermediary substrate that captures cells and their secreted proteins, enabling single-cell level detection without requiring complex specialized equipment. The substrate acts as a mediator between the cells and the detection system, preserving spatial information while using standard laboratory equipment

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If supernatant is collected from thousands of cells for ELISA detection, then the signal strength is sufficient for detection, but the cell-to-cell heterogeneity and locoregional correlation are lost due to implicit averaging

Engineering Contradiction:
Improvedetection sensitivityVSAvoidcell-to-cell heterogeneity information
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The invention segments the sample into individual cell units captured on a substrate, allowing detection of proteins from each cell separately. This eliminates the need to aggregate thousands of cells, preserving cell-to-cell heterogeneity information while maintaining sufficient signal strength for reliable detection

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from bulk liquid phase detection to surface-bound single-cell detection. By capturing cells on a substrate and detecting proteins in the localized extracellular matrix surrounding each cell, the method adds spatial dimensionality to the detection, enabling both sensitivity and heterogeneity preservation

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If ELISpot or FluoroSpot assays are used for single-cell protein detection, then spatial information is preserved, but the signal is too weak requiring specialized membrane-coated plates and long incubation times

Engineering Contradiction:
Improvesingle-cell spatial resolutionVSAvoidincubation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention extracts and concentrates the secreted proteins in the localized extracellular matrix surrounding each captured cell, rather than relying on diffuse spotting. This concentration effect strengthens the signal without requiring specialized membrane-coated plates or extended incubation times, thus resolving the contradiction between spatial resolution and time loss

Inventive Principle:
Principle #2Taking out (Extraction)

4Ease of manufacture

If conventional fluorophores are used for detection, then the assay can be performed with standard equipment, but the sensitivity is insufficient to detect low-abundance proteins at early time-points

Engineering Contradiction:
Improveequipment accessibilityVSAvoiddetection sensitivity
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The invention employs plasmonic-fluors as composite nanomaterials that combine fluorescent properties with plasmonic enhancement capabilities. These composite materials provide signal amplification for detecting low-abundance proteins at early time-points while maintaining compatibility with standard epifluorescence microscopy equipment, thus resolving the contradiction between ease of manufacture and measurement precision

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides high-resolution, sensitive, and quantitative detection of protein secretion, revealing cell-to-cell heterogeneity and directionality, and can detect low-abundance proteins at early time-points, overcoming the limitations of existing techniques by using readily available equipment and reagents.

Implementation Method 1

The use of plasmonic-fluors, which have shown to be ultrabright biolabels that can be used to image single molecules

Methodology Applied
Scientific EffectPlasmon-enhanced fluorescence: Fluorescence

Implementation Method 2

plasmon-enhanced fluoro-dot assays... uses ultrabright plasmonic-fluors to detect and quantify protein secretion

Methodology Applied
Scientific EffectPlasmon resonance: Resonance

Data Source

PatentUS20230176066A1Plasmon-enhanced fluoro-dot assays
Publication Date: 2023.06.08 WASHINGTON UNIV IN SAINT LOUIS
  • US20230176066A1 patent drawing
  • US20230176066A1 patent drawing
  • US20230176066A1 patent drawing

AI summary

Described herein are methods and kits for performing plasmon-enhanced fluoro-dot assays. These assays enable observing a correlation between a chemical stimulus and a biological response of cultured cells in vitro.